Latest Form 4 insider transactions

Tomas Navratil, CHIEF DEVELOPMENT OFFICER of GLAUKOS Corp, sold 1,527 shares of common stock on October 5, 2026.

H. Craig Moody, a Director of Security National Financial Corp, reported multiple transactions in common stock on October 1, 2026.

Edward K Aldag Jr, Chairman, President & CEO and a Director of Medical Properties Trust Inc, reported a transaction in 109,433 shares of common stock on October 7, 2026.

R Steven Hamner, Executive Vice President & CFO and a Director of Medical Properties Trust Inc, reported a transaction in 48,548 shares of common stock on October 7, 2026.

Larry H Portal, SVP, Senior Advisor to the CEO of Medical Properties Trust Inc, reported a transaction in 4,048 shares of common stock on October 7, 2026.

James Kevin Hanna, Senior VP, Controller & CAO of Medical Properties Trust Inc, reported a transaction in 3,295 shares of common stock on October 7, 2026.

Rosa Handley Williams, SVP of Operations of Medical Properties Trust Inc, reported a transaction in 1,938 shares of common stock on October 7, 2026.

Charles R Lambert, SVP of Finance and Treasurer of Medical Properties Trust Inc, reported a transaction in 2,347 shares of common stock on October 7, 2026.

Salman Hassan Khan, Chief Financial Officer of MARA Holdings, Inc., reported a transaction in 9,210 shares of common stock on October 5, 2026.

Arvind Nithrakashyap, Chief Technology Officer and a Director of Rubrik, Inc., sold 38,460 shares of common stock on October 5, 2026.

Patricia Gallup and 1 other reported changes in beneficial ownership of Pc Connection Inc common stock on October 5, 2026.

Andrew John Partridge, Chief Growth Officer of GRAIL, Inc., sold 7,873 shares of common stock on October 5, 2026 for $146.39 per share.

Aaron Freidin, Chief Financial Officer of GRAIL, Inc., sold 23,619 shares of common stock on October 5, 2026 for $146.39 per share.

Janet Lee, GC & Corporate Secretary of Synopsys Inc, sold 1,144 shares of common stock on October 6, 2026.

Brady Brewer, ceo, International of Starbucks Corp, sold 1,641 shares of common stock on October 5, 2026 for $94.76 per share.

Jennifer Scott Perry, Chief Operating Officer of Bicycle Therapeutics Plc, sold 356 shares of common stock on October 2, 2026.

Tyler Herb, Chief Accounting Officer of Figma, Inc., sold 1,418 shares of common stock on October 5, 2026 for $21.62 per share.

Todd Meinert, SVP & Chief Accounting Officer of MGM Resorts International, reported multiple transactions in common stock on October 5, 2026.

Ayesha Khanna Molino, CHIEF OPERATING OFFICER of MGM Resorts International, reported multiple transactions in common stock on October 5, 2026.

Jamie L. Reynoso, CEO, Medicare Advantage of Clover Health Investments, Corp. /De, sold 2,006 shares of common stock on October 7, 2026 for $4.63 per share.

Leticia Adriana Raele, INTERIM CFO of Algorhythm Holdings, Inc., received 1,144,552 shares of common stock on September 15, 2026.

John Mcmanus, CHIEF LEGAL ADMIN OFC AND SECY of MGM Resorts International, reported multiple transactions in common stock on October 5, 2026.

Jonathan S Halkyard, CHIEF FINANCIAL OFFICER of MGM Resorts International, reported multiple transactions in common stock on October 5, 2026.

Gary M Fritz, President, Interactive of MGM Resorts International, reported multiple transactions in common stock on October 5, 2026.

Brendan Mulligan, General Counsel and Secretary of Figma, Inc., sold 20,701 shares of common stock on October 5, 2026 for $21.74 per share.

William Hornbuckle, CEO AND PRESIDENT and a Director of MGM Resorts International, reported multiple transactions in common stock on October 5, 2026.

Steven O Newhouse, a Director of Reddit, Inc., received 115 shares of common stock on October 5, 2026.

De Lima Filho Pedro Batista, a Director of Brazilian Electric Power Co, sold 2,333,900 shares of common stock on October 5, 2026.

Javier Olivan, Chief Operating Officer of Meta Platforms, Inc., sold 1,575 shares of common stock on October 5, 2026 for $728.08 per share.

Blake Borgeson, a Director of Recursion Pharmaceuticals, Inc., sold 50,000 shares of common stock on October 6, 2026 for $4.84 per share.